3. PMA exposure protocol and validation. PMA is a high-affinity photo-reactive DNA binding dye, which upon light exposure covalently binds to the DNA molecule and inhibits downstream PCR amplification. The dye is impermeable to cell membranes, and would only bind to intracellular gene targets when cell walls and membranes are compromised.
[1]. In activated sludge, PMA could be absorbed onto the suspended solids, compromising its ability to intercalate with extracellular DNA and inhibit downstream PCR detection. To account for this, we used the PMA exposure protocol optimized by Bae and coworkers [2] , and validated it in the sludge fraction used in this study.
E. coli PI7 was grown in LB with 16 µg/mL meropenem at 37 °C to an OD 600 of 0.7. Cells were washed twice with 1X PBS, and resuspended in 30% of the original culture volume.
Washed cells were dispensed in 1 mL aliquots, and half of the aliquots were heat-lysed at Table S1 shows the results of the bla NDM-1 qPCR quantification in PMA-treated and nontreated sludge fractions. At these exposure conditions, PMA completely inhibited the PCR signal from the cells with uncompromised cell membranes. As Bae and coworkers described, PMA permeation in cells with uncompromised membranes was also observed, accounting for a 13-15% penetration in cells with uncompromised cell membranes.
Although penetration in cells with uncompromised cell membranes occurs, inhibition of extracellular DNA or cells with compromised cell membranes is completely inhibited.
4. Calculation of detection limit for culture-based methods. 100 µL of diluted or nondiluted sludge were plated in MUG-EG agar plates supplemented with meropenem (8 μg/mL). The detection limit was established based on the minimum cell density (MCD)
required to detect at least 10 CFU when plating 100 µL of non-diluted sludge. As the average MLSS corresponded to 4 g/L, each 100 µL aliquot contained 4 x 10 -4 g of sludge biomass. Figure S1 . blaNDM-1 decay curves in PMA-treated biomass samples from anaerobic sludge mesocosms at (a) 0 µg/L (n = 3) and (b) 100 µg/L of meropenem (n = 3). Plots comprise data from three independent replicate runs for each antibiotic condition. 
